Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
51.99
-0.85 (-1.61%)
Nov 13, 2024, 4:00 PM EST - Market closed
Janux Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$65.10
Upside
+25.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +21.18% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +92.34% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +32.72% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +92.34% | Sep 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +34.64% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +21.18% | Aug 19, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $47 → $42 | Hold | Maintains | $47 → $42 | -19.22% | Aug 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +92.34% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $74 | Buy | Reiterates | $74 | +42.34% | Aug 8, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $47 | Hold | Initiates | $47 | -9.60% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +21.18% | May 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +92.34% | May 9, 2024 |
| Wedbush | Wedbush | Buy Maintains $53 → $74 | Buy | Maintains | $53 → $74 | +42.34% | May 8, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +34.64% | Apr 16, 2024 |
| BTIG | BTIG | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +19.25% | Mar 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $100 | Buy | Initiates | $100 | +92.34% | Mar 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.